05:46:57 EDT Sun 21 Jul 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

SEC cites New Jersey's Anglim for OTC manipulations

2023-07-18 20:50 ET - Street Wire

Also Street Wire (U-DIGAF) Digatrade Financial Corp

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

The U.S. Securities and Exchange Commission has filed civil fraud charges against James Anglim, a brokerage employee from New Jersey accused of helping with the manipulations of Vancouver's Digatrade Financial Corp. and four other stocks. The SEC claims that Mr. Anglim helped hidden insiders unload millions of illegally issued shares on the markets over an eight-year period. The sales resulted in proceeds of $26.6-million, according to the SEC. (All figures are in U.S. dollars.)

The allegations are contained in a civil complaint that the SEC filed on Monday, July 17, in federal court in Boston. The sole defendant is Mr. Anglim, 50, who has been a brokerage industry employee since 1998. During the scheme, he worked at firms that were registered as market-makers.

The complaint cites Mr. Anglim for helping with the illegal sale of shares in five companies, with a portion of the scheme from 2016 and 2017 including Digatrade Financial. The SEC previously charged a Vancouver man, Bradley Moynes, claiming that he ran a $6-million pump-and-dump on the OTC Markets with Digatrade. The SEC said that Mr. Moynes unloaded millions of shares amidst manipulative trades and a paid promotion. (Mr. Moynes settled that case out of court, agreeing to pay $1.5-million, without admitting any wrongdoing.)

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed